Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective

Decentralized clinical trials (DCTs) have the potential to improve accessibility, diversity, and retention in clinical trials by moving trial activities to participants’ homes and local surroundings. In this study, we conducted semi‐structured interviews with 20 European regulators to identify regul...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Amos J., van Rijssel, Tessa I., Zuidgeest, Mira G. P., van Thiel, Ghislaine J. M. W., Askin, Scott, Fons‐Martínez, Jaime, De Smedt, Tim, de Boer, Anthonius, Santa‐Ana‐Tellez, Yared, Gardarsdottir, Helga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540149/
https://www.ncbi.nlm.nih.gov/pubmed/35488483
http://dx.doi.org/10.1002/cpt.2628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540149/
https://www.ncbi.nlm.nih.gov/pubmed/35488483
http://dx.doi.org/10.1002/cpt.2628

Ejemplares similares